Having an organ transplant can feel like a new lease on life!
You find that you can suddenly do more of the things that you enjoy. However, new recipients are sometimes overwhelmed with all the requirements of post-transplant living. Read the full story on CareDx.com.
A new method of donor-lung distribution is projected to decrease the number of candidate deaths who are on the waitlist for lung transplant, according to a study by Cleveland Clinic and the U.S. Scientific Registry of Transplant Recipients (SRTR) published in The American Journal of Transplantation. Read the full article in Medical Life Sciences.
This video explores reasons for organ transplants and the beginning of a patient’s transplant journey. It also highlights the Scientific Registry of Transplant Recipients (SRTR) as a valuable resource for transplant-related information. Watch the video from SRTR.
A new policy action now in effect means some Black kidney candidates will be eligible to receive waiting time modifications and increase their waiting times (and potentially their prioritization for transplant). Read more from UNOS.
A Missouri University of Science and Technology researcher is looking for ways artificial intelligence can improve how kidney donors are matched with recipients.
Missouri S&T engineering management assistant professor Casey Canfield is leading a research effort to develop AI software that can streamline the matching process. Read more from St. Louis Public Radio.
In 1984, Chelsea Roman entered the world two months early. Her mom went into labor in a parking lot. Fortunately, that parking lot was across the street from a hospital.
Chelsea’s mom walked to the hospital in severe pain, and before they could even numb her up, she endured a delivery by cesarian. Chelsea was stillborn. For the first five minutes of her life, Chelsea was not breathing. Read more about Chelsea’s transplant journey on CareDx.com.
Adults with graft-versus-host disease who were treated with a three-drug regimen with cyclophosphamide after transplant may have improved survival rate compared with those treated with a two-drug regimen.
Patients treated with a three-drug regimen — cyclophosphamide, tacrolimus and mycophenolate mofetil — after undergoing a stem cell transplant had increased one-year graft-versus-host disease (GVHD) relapse-free survival compared with those treated with a two-drug regimen, according to findings from a phase 3 trial. Read more in Cure Today.
Healio and Cardiology Today have compiled a list of the most-read news of 2022 in cardiology.
Readers were most interested in a meta-analysis questioning the association between statin-induced LDL lowering and CV outcomes; firsts in xenotransplantation of genetically modified pig hearts; how moderate wine intake with meals may reduce type 2 diabetes risk; and more. Read the full story in Healio.
Growing up in a Spanish-speaking family, Gladiz Martinez, AG-CNS ’20, BSN ’08, often served as a reluctant family interpreter.
“In the outside world, we had to speak English,” she says. “Later, there were a lot of fights – with me being a rebellious teenager and not wanting to be the interpreter anymore.” Read more from CU Anschutz.
These organs that live for more than a century could raise the age of potential donors, perhaps shortening waits for the life-saving procedure
Your liver could outlive you—even into the triple-digits, new research suggests.
Using the United Network for Organ Sharing’s organ transplant database, scientists assessed the ages of 253,406 livers transplanted between 1990 and 2022. Their analysis revealed that 25 of them had survived for more than 100 years.
Read the full article in Smithsonian Magazine.